Treating pediatric nonalcoholic fatty liver disease with cysteamine: is adiponectin the key?

J Pediatr. 2012 Oct;161(4):579-81. doi: 10.1016/j.jpeds.2012.05.052. Epub 2012 Jun 26.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adiponectin / chemistry*
  • Cysteamine / pharmacology*
  • Humans
  • Protein Multimerization / drug effects*

Substances

  • Adiponectin
  • Cysteamine